Intensive adverse drug reaction monitoring in various speciality clinics of a teriary care hospital in North India

International Journal of Medical Toxicology and Legal Medicine

Volumn 4, Issue 1, 2001, Pages 1-4

  Doomra, R ^a   Gupta, S K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

ADR monitoring; Adverse drug reactions (ADR)

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; AZITHROMYCIN; CARBAMAZEPINE; CEFTRIAXONE; CELECOXIB; CIPROFLOXACIN; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; DAUNORUBICIN; DICLOFENAC; HALOPERIDOL; IBUPROFEN; IMIPRAMINE; INDOMETACIN; LITHIUM SALT; MELOXICAM; METHOTREXATE; METRONIDAZOLE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; RISPERIDONE; STEROID; TRAZODONE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD DYSCRASIA; CANCER; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; EDEMA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; GASTRITIS; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEPATITIS; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NAUSEA; NEUTROPENIA; OSTEOPOROSIS; OUTPATIENT; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PSYCHIATRIC DEPARTMENT; SKIN MANIFESTATION; THROMBOCYTOPENIA; VOMITING;

EID: 0038078107     PISSN: 09720448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cohen JS. Ways to minimize ADRs - Individualized doses and common sense are key. Post Grad Med 1999; 106: 163-172.
2. Gholasni K, Shalvani G. Factors associated with preventability, predictability and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236-40.
3. Bates DW, Spell N, Cullen DJ, Bundick E, Laind N et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307-311.
4. Bhatt AD. Drug related problems and adverse drug events: Negligence, litigation and prevention. JAPI 1999; 47: 715-720.
5. Uppal R, Jhaj R, Malhotra S. Adverse drug reactions among inpatients in a north Indian referral hospital. Natl Med J Ind 2000; 13: 16-19.
6. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 (2): 239-47.
7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta analysis of prospective studies. JAMA 1998; 279(15) : 1200-5.
8. Taylor D, Clark DW, Dovey SM, Tilyard MW. The prescribing and adverse reactions of non-steroidal anti-inflammatory drugs in general practice: A Dunedin study. NZ Med J 1994; 107(981) : 263-6.
9. Singh G, Rosen-Ramey D. NSAID induced gastrointestinal complications: The ARAMIS prespective - 1997. Arthritis, Rheumatism and Ageing Medical Information System. J Rheumatol Supp 1998; 51 : 8-16.
10. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol. 1999; 26 (Supp 56): 18-24.
11. Leape LL, Brennan TA, Laird N, Lawthers AG, Lacalio AR, Barnes BA et al. The nature of adverse events in hospitalized patients. Results of the Havard Medical Practise study II. N Engl J Med 1991; 324: 377-84.
12. Gleckman RA, Borrego F. Adverse reactions to antibiotics: Clues for recognizing, understanding and avoiding them. Postgrad Med 1997; 101(4): 97-8.
13. Dhikav V, Gosain R, Gupta SK. Adverse drug reactions in the Department of Psychiatry, All India Institute of Medical Sciences: Incidence and preventability. Indian J Pharmacol 2001; 33 (1) : 70.
14. Pollock BG. Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry 1999; 60 (Suppl 20): 4-8.